Legemiddelbruk og hoftebrudd
|
|
- Nora Townsend
- 5 years ago
- Views:
Transcription
1 Legemiddelbruk og hoftebrudd Oppsummering av ph.d. GerIT LIS Marit Stordal Bakken Haraldsplass Diakonale Sykehus
2 U N I V E R S I T Y O F B E R G E N Potentially inappropriate drug use and hip fractures among older people Pharmacoepidemiological studies Marit Stordal Bakken September 11 th 2015
3 Contents Background Research aims Study I (paper I) Study II (papers II and III) Implications 3
4 Drug use among older people Norwegian nursing home patients: 10 Acutely hospitalized Irish 85 year-olds: 7 (regular only) Swedish general population 70-79: : : Soraas 2014, Dalleur 2014, Hovstadius
5 Psychotropic drugs Antidepressants Anxiolytics Hypnotics Antipsychotics Despair 1894 The scream 1893 Sleepless night 1920 Self portrait in hell 1903 Edvard Munch 5
6 Psychotropic drug use Drug group Women 60+ Men 60+ Antidepressants 14 % 7 % Anxiolytics 17 % 9 % Hypnotics & sedatives 29 % 16 % Antipsychotics 5 % 3 % > Increases with age Higher numbers in nursing homes Community-dwelling 60+, proportion of the population using (The Norwegian Prescription database, NorPD) 6
7 Inappropriate drug use Risks outweigh benefits Major impact on health outcomes Number of drugs and psychotropic drug use associated with adverse drug events Drug use and prescribing quality among acutely hospitalized older people in Norway? Petrovic 2012, Fastbom 2015, Pirmohamed 2004, Wu 2010, Bradley
8 Hip fractures 8
9 Hip fractures Highly prevalent - critical events - substantial costs Combination osteoporosis + fall Psychotropics Coupland 2011, Haney 2010, Cumming
10 Contents Background Research aims Study I (paper I) Study II (papers II and III) Implications 10
11 Overall research aims To examine aspects of prescribing quality among older people acutely admitted to hospital (study I, paper I) To explore associations between exposure to psychotropic drugs and the risk of hip fracture (study II, papers II and III) 11
12 Contents Background Research aims Study I (paper I) Study II (papers II and III) Implications 12
13 Intermediate care nursing home unit Haukeland University Hospital Haraldsplass Deaconess Hospital Intermediate care nursing home unit Municipality of Bergen 13
14 Intermediate care nursing home unit Inclusion criteria >70 years, community-dwelling Acutely admitted to hospital Transfer within 72 hours Discharge (home) within 3 weeks realistic Informed consent required Exclusion criteria Surgery, intensive care, delirium, severe dementia Multidisciplinary geriatric approach 14
15 Research aims To identify inappropriate prescribing among older people ( 70) on acute hospital admission and on discharge from an intermediate-care nursing home unit (INHU) and hospital wards (HWs) To compare changes in inappropriate prescribing within and between these groups during stay 15
16 Methods Study period August June 2008 Data collection Demographics: age, gender, length of stay Medications (admission and discharge): regular + on demand Outcome measures Drug use Potentially inappropriate medicines (PIMs) NORGEP: 21 drugs + 15 combinations to avoid Drug-drug interactions (DDIs) interaksjoner.no: 4 point severity scale 16
17 Study population 400 hospital 200 interm hospital 133 Drop-outs -complete medication lists unavailable (6) -not retrospectively identifiable in hospital datasystems (10) -not meeting inclusion criteria or randomized 1 (80) -consent withdrawn (14) 17
18 Results I Demographics N=290 (INHU=157, HW=133) Mean age 85 years, 71% women Drug use Mean drugs Increased: analgesics, laxatives, hypnotics, cough medications Reductions: none HW hospital ward INHU intermediate care nursing home unit 18
19 Results II Potentially inappropriate medicines (PIMs) 23/34 (eligible) NORGEP items At least one PIM: admission 24% discharge 35% Most frequent PIM: 3 psychotropic drugs PIMs increased: 3 psychotropic drugs, NSAIDs combinations PIMs reduced: none INHU patients less likely to have diazepam initiated HW hospital ward INHU intermediate care nursing home unit 19
20 Results III Drug-drug interactions (DDIs) At least one DDI: admission 53% discharge 68% Severe DDIs ( should be avoided ) scarce on admission, remained unchanged in both settings No significant group differences Trend: DDIs precautions necessary increased more in HWs HW hospital ward INHU intermediate care nursing home unit 20
21 Summary of results study I Drug use extensive and PIMs and DDIs frequent on admission - increased regardless of setting Several psychotropic drugs Unadvisable drug combinations including NSAIDs Severe DDIs were scarce No reductions in number of drugs, PIMs or DDIs were identified in either setting Minor differences in prescribing quality identified 21
22 Contents Background Research aims Study I (paper I) Study II (papers II and III) Implications 22
23 Psychotropic drugs Antidepressants Anxiolytics Hypnotics Despair 1894 The scream 1893 Sleepless night 1920 Edvard Munch 23
24 Aims To examine associations between antidpressant (paper II) and anxiolytic or hypnotic (paper III) drug exposure and the risk of hip fracture among older (60+) Norwegians To examine associations between exposure to hypnotic drugs and the time of hip fracture (paper III) Provided associations found, to estimate attributable risk: effect on number of hip fractures per year (papers II and III) 24
25 The Norwegian Prescription Database All ~ 2.8 million prescriptions for antidepressants All ~ 7.5 million prescriptions for anxiolytics and hypnotics The Central Population Registry All ~ persons born < 1945 The National Hip Fracture Registry All ~ hip fractures Research database
26 Methods Standardized incidence ratio (SIR) Birth year, sex, time of year of fracture Hip fracture incidence during drug exposure vs Hip fracture incidence during non-exposure SIR >1 indicates increased risk of hip fracture during exposure Engeland
27 Exposed and unexposed person time
28 Methods - assumptions Purchased drugs = consumed drugs Exposed person time = number of days corresponding to number of defined daily doses (DDD) prescribed Engeland
29 Paper II 29
30
31 Antidepressants Therapeutic subgroups (ATC) Tricyclic antidepressants, TCAs Selective serotonergic reuptake inhibitors, SSRIs Others 31
32 Results Therapeutic subgroups SIR(95% CI) Any AD TCAs SSRIs Others Men 1.9 ( ) 1.4 ( ) 2.1 ( ) 1.6 ( ) Women 1.7 ( ) 1.4 ( ) 1.7 ( ) 1.6 ( ) All 1.7 ( ) 1.4 ( ) 1.8 ( ) 1.6 ( ) AD = antidepressant drug SIR >1 increased risk of hip fractures during AD exposure 32
33 Antidepressants Therapeutic subgroups (ATC) Tricyclic antidepressants, TCAs Selective serotonergic reuptake inhibitors, SSRIs Others Serotonergic effects High/intermediate Low/no 33
34 Results Serotonergic effects SIR(95% CI) Any AD Low/no High/intermediate Men 1.9 ( ) 1.3 ( ) 1.9 ( ) Women 1.7 ( ) 1.2 ( ) 1.7 ( ) All 1.7 ( ) 1.2 ( ) 1.7 ( ) Low/no TCAs: nortryptiline, doxepin, trimipramine. Others: moclobemide, bupropion, reboxetine. High/intermediate All SSRIs. TCAs: clomipramine, amitryptiline. Others: mianserin, mirtazapine, venlafaxine, duloxetine. 34
35 Results Serotonergic effects SIR(95% CI) Any AD Low/no High/intermediate Men 1.9 ( ) 1.3 ( ) 1.9 ( ) Women 1.7 ( ) 1.2 ( ) 1.7 ( ) All 1.7 ( ) 1.2 ( ) 1.7 ( ) Low/no TCAs: nortryptiline, doxepin, trimipramine. Others: moclobemide, bupropion, reboxetine. High/intermediate All SSRIs. TCAs: clomipramine, amitryptiline. Others: mianserin, mirtazapine, venlafaxine, duloxetine. 35
36 Results Age and gender SIR (95% CI) All <1915 Men 1.9 ( ) 2.9 ( ) 2.2 ( ) 1.4 ( ) 1.0 ( ) Women 1.7 ( ) 2.5 ( ) 1.9 ( ) 1.4 ( ) 1.2 ( ) All 1.7 ( ) 2.6 ( ) 1.9 ( ) 1.4 ( ) 1.2 ( ) 36
37 Results Attributable risk in % Any N06A Any TCAs Any SSRIs Any Others Any Low/no 5-HT Any High/int. 5-HT All ~ 300 fractures yearly ~ 2000 fractures
38 Paper III 38
39 39
40 40
41 Results SIR (95% CI) Anxiolytics & z-hypnotics Any SAB LAB Z-hypnotics anxiolytic (short acting bzd) (long acting bzd) Men 1.6 ( ) 1.7 ( ) 1.2 ( ) 1.3 ( ) Women 1.4 ( ) 1.4 ( ) 1.2 ( ) 1.1 ( ) All 1.4 ( ) 1.5 ( ) 1.3 ( ) 1.2 ( )* Anxiolytics: diazepam, oxazepam, alprazolam and hydroxyzine SABs: oxazepam, alprazolam and midazolam LABs: diazepam, nitrazepam and flunitrazepam Z-hypnotics: zopiclone, zolpidem 41
42 Results SIR (95% CI) Anxiolytics & z-hypnotics Any SAB LAB Z-hypnotics anxiolytic (short acting bzd) (long acting bzd) Men 1.6 ( ) 1.7 ( ) 1.2 ( ) 1.3 ( ) Women 1.4 ( ) 1.4 ( ) 1.2 ( ) 1.1 ( ) All 1.4 ( ) 1.5 ( ) 1.3 ( ) 1.2 ( )* Anxiolytics: diazepam, oxazepam, alprazolam and hydroxyzine SABs: oxazepam, alprazolam and midazolam LABs: diazepam, nitrazepam and flunitrazepam Z-hypnotics: zopiclone, zolpidem * Day/night 42
43 Results SIR (95% CI) Fractures day (08:00-19:59) and night (20:00-07:59) Z-hypnotics day¹ Z-hypnotics night¹ Exposed person days n SIR n SIR ( ) ( ) DDD ( ) ( ) ¹ Time of fracture known in 51% of cases (hip fractures occurring during exposure to hypnotic drugs) Hypnotics: benzodiazepine derivates (nitrazepam, flunitrazepam, midazolam),benzodiazepine-related drugs or z-hypnotics (zopiclone, zolpidem) and melatonin receptor agonists (melatonin) 43
44 Results Attributable risk in % Any anxiolytic drug Any hypnotic drug Any SAB, LAB or z-hypnotic drug Any z-hypnotic drug Z-hypnotics day Z-hypnotics night Anxiolytics: diazepam, oxazepam, alprazolam and hydroxyzine Hypnotics: nitrazepam, flunitrazepam, midazolam, zopiclone, zolpidem and melatonin SABs: oxazepam, alprazolam and midazolam LABs: diazepam, nitrazepam and flunitrazepam Z-hypnotics: zopiclone, zolpidem 44
45 Strengths and limitations Nationwide study Prospective design 6-year follow-up Time-varying exposure No clinical information Confounding Comorbidities Polypharmacy Misclassification 45
46 Summary of results study II Increased risk of hip fracture among persons using Antidepressants - SSRIs/similar properties Anxiolytics - SABs > LABs Hypnotics - excess risk at night High number of fractures attributable to psychotropic drug use 46
47 Contents Background Research aims Study I (paper I) Study II (papers II and III) Implications 47
48 Implications for clinical practice Main findings Inappropriate prescribing common - psychotropics Clinically relevant associations psychotropics - hip fracture Improved drug treatment for older people needed Look for inappropriate prescribing Multidisciplinary medication reviews Recommended psychotropic drugs (SSRIs, SABs and z-hypnotics) not safer than traditional alternatives with regard to hip fractures Non-pharmacological treatment options Be aware of fall risk and possible effects on bone tissue Follow-up Haney 2010, Bondesson 2013, Dalleur
49 Appropriate drug therapy Evidence-based knowledge Drug use widespread Inappropriate prescribing (IP) widespread Increased risk of severe adverse events, readmissions and mortality Check-lists and medication reviews reduce IP Evidence scarce Clinical outcomes of interventions Reductions in falls and readmissions Multifaceted interventions promising (e.g. CGA) Moriarty F et al Eur J Clin Pharmacol 2015, Gallagher P et al Int J Clin Pharmacol 2008, 49 Beijer H et al Pharm World Sci 2002, Ebbesen J Arch Intern Med 2001, Petrovic M et al Drugs Ageing 2012, Saltvedt I et al JAGS 2002
50 Implications for research Clinical outcomes Serotonergic effects on bone tissue Association z-hypnotics and night-time fractures 50
51 Thank you for your attention The sun EM
52 Study participants vs real-life patients GerIT MSB 52
53 Approval of drugs Pre-marketing studies Recommendations (drugs intended for chronic use) 1000 patients in total 100 of these 12 months (80% of drugs ) Dujinhoven R et al PLoS Med
54 Number of patients studied prior to approval Dujinhoven R et al PLoS Med
55 Approval of drugs Safety and long-term efficacy knowledge lacking Insufficient number of patients studied before marketing 50% of drugs, severe adverse effects identified after approval 10% restricted use 3% of drugs withdrawn Pharmacovigilance reporting matters! Generalizability limited Older adults frequent users, vulnerable AND under-represented Dujinhoven R et al PLoS Med 2013, Schroll J et al PLoS One
56 GerIT MSB 56
Stronger together - optimizing pharmacotherapy on geriatric wards?
Stronger together - optimizing pharmacotherapy on geriatric wards? Clinicamp FOD 27/4/2018 Dr. Jean-Claude Lemper ( Geriater UZ Brussel) Apr. Julie Hias (ziekenhuisapotheker UZ Leuven) Project College
More informationRepeated dispensing of codeine is associated with high consumption of benzodiazepines
Norsk Epidemiologi 2008; 18 (2): 185-190 185 Repeated dispensing of codeine is associated with high consumption of benzodiazepines Liliana C. Bachs 1, Jørgen G. Bramness 2, Anders Engeland 2,3 and Svetlana
More informationSupplementary Online Content
Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published
More informationSelf-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database
Norsk Epidemiologi 2014; 24 (1-2): 209-216 209 Self-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database Svetlana Skurtveit
More informationFalls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in
This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor
More informationPROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF GUIDELINE REASON FOR GUIDELINE WHAT THE GUIDELINE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Medicines Guideline: Hypnotic Medication Compliance with NICE
More informationZolpidem Is Independently Associated With Increased Risk of Inpatient Falls
ORIGINAL RESEARCH Zolpidem Is Independently Associated With Increased Risk of Inpatient Falls Bhanu Prakash Kolla, MD, MRCPsych 1, Jenna K. Lovely, PharmD, RPh, BCPS 2, Meghna P. Mansukhani, MD 3, Timothy
More informationAn Evaluation of the Prevalence of Potentially Inappropriate Medications in a Hospital in Northern Sweden
An Evaluation of the Prevalence of Potentially Inappropriate Medications in a Hospital in Northern Sweden A cross-sectional study using the EU (7)- PIM list and the Swedish indicators for evaluating the
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationSleep and Falls. Katie L. Stone, Ph.D. October 4-6, 2015
Sleep and Falls Katie L. Stone, Ph.D. October 4-6, 2015 U13 Conference Series Sleep, Circadian Rhythms and Aging: New Avenues for Improving Brain Health, Physical Health and Functioning Bethesda, MD Disclosures
More informationUse of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway
Eur J Clin Pharmacol (2012) 68:311 319 DOI 10.1007/s00228-011-1124-2 PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway Svein
More informationPotentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay
Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay Background Polypharmacy in the Elderly 40% seniors are using 5-9 different classes of
More informationRational prescribing in the older adult. Assoc Prof Craig Whitehead
Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade
More informationFriend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines
Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines Program Learning Objectives At the conclusion of the activity, participants should be able to: Have a basic understanding
More informationPsychotropic Drug-Related Fall Incidents in Nursing Home Residents Living in the Eastern Part of The Netherlands
Drugs R D DOI 10.1007/s40268-017-0181-0 ORIGINAL RESEARCH ARTICLE Psychotropic Drug-Related Fall Incidents in Nursing Home Residents Living in the Eastern Part of The Netherlands Sarah I. M. Janus 1 Gezinus
More informationIndex. E Elderly and dementia, 2 Epilepsy, 59 Escitalopram, 51, 87 Estazolam, 101 Extrapyramidal symptoms (EPS), 18
A Abilify, 143 Absolute neutrophil count (ANC), 29 Acetylcholine (Ach), 14, 15 ACTivities of daily living and cognition (ACTION) study, 167 AD Anti-inflammatory Prevention Trial (ADAPT) study, 156 Adverse
More informationProfessor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065
ARABIIC Professor David Castle Ms. Nga Tran St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 (03) 9288 4147 (03) 9288 4751 Psychiatric Medication Information / Arabic 1 Psychiatric
More informationAnxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming
More informationPOLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE
POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of
More informationAntidepressant use and risk of adverse outcomes in people aged years: cohort study using a primary care database
Coupland et al. BMC Medicine (2018) 16:36 https://doi.org/10.1186/s12916-018-1022-x RESEARCH ARTICLE Open Access Antidepressant use and risk of adverse outcomes in people aged 20 64 years: cohort study
More informationAssessing the impact of medicine on falls risk
Medicines and falls Assessing the impact of medicine on falls risk This presentation is designed for registered nurses, but may be applicable to all nursing staff at the aged care facility. It is part
More informationSouth London and the Maudsley NHS Foundation Trust Medicines Formulary
South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationTreating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP
Treating Anxiety Disorders Adil Virani, BSc (Pharm), Pharm D, FCSHP Outline! Michelle s Case! Types of anxiety disorders! Goals of therapy! Treatment options and guidelines! Pharmacological options! Benzodiazepines
More informationConflict of interest declaration and sources of funding
Potentially Inappropriate Prescribing immediately prior to Long-Term Care admission (PIP in LTC): Validation of tools for their future use across Ontario Bruyère CLRI Webinar March 24 th, 2016 and Bruyère
More informationUse of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
More informationPrescribing of anti-osteoporotic therapies following the use of Proton Pump Inhibitors in general practice
Prescribing of anti-osteoporotic therapies following the use of Proton Pump Inhibitors in general practice B. McGowan, K. Bennett, J. Feely Department of Pharmacology & Therapeutics, Trinity Centre for
More informationConcurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case Control Study
Neurol Ther (2015) 4:39 51 DOI 10.1007/s40120-015-0026-0 ORIGINAL RESEARCH Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case Control
More informationChanging patterns of sedative use over time in older adults in Ontario
Changing patterns of sedative use over time in older adults in Ontario Andrea Iaboni, MD, DPhil, FRCPC Toronto Rehabilitation Institute University Health Network Faculty/Presenter Disclosure Faculty: Andrea
More informationPharmacology in the Elderly
Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol
More informationMedication safety in vulnerable patient groups - Elderly patients -
Woodennature/CC-BY-SA-3.0 http://theintelligence.de Medication safety in vulnerable patient groups - Elderly patients - 20th Congress of EAHP 25-27 March, 2015, Hamburg, Germany Dr. rer. nat. Beate Wickop
More informationPotentially inappropriate medications and drug drug interactions in home-dwelling people with mild dementia
RESEARCH ARTICLE Potentially inappropriate medications and drug drug interactions in home-dwelling people with mild dementia Ragnhild Oesterhus 1,2, Dag Aarsland 1,3, Hogne Soennesyn 1, Arvid Rongve 2,4,
More informationYoung women, antidepressants and suicide
Young women, antidepressants and suicide A report on the situation in Sweden 2013 Janne Larsson We have read in the media that psychiatric disorders and the number of suicides are increasing among young
More informationInterdisciplinary detection of potential drug related problems in older people
Interdisciplinary detection of potential drug related problems in older people Prof. dr. Mirko Petrovic Department of Internal Medicine, Ghent University Department of Geriatrics, Ghent University Hospital,
More informationFALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C
FALLS PREVENTION S H I R L E Y H U A N G, M S c, M D, F R C P C S T A F F G E R I A T R I C I A N T H E O T T A W A H O S P I T A L B R U Y E R E C O N T I N U I N G C A R E W I N C H E S T E R D I S T
More informationCHOOSING WISELY TO IMPROVE CARE FOR GERIATRIC PATIENTS
CHOOSING WISELY TO IMPROVE CARE FOR GERIATRIC PATIENTS About Choosing Wisely First conceived by the National Physicians Alliance Funded by an ABIM Foundation grant Created 3 lists of steps physicians could
More informationAn Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population
An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population A Population-Based Case-Control Study Hsin-I Shih, Che-Chen Lin, Yi-Fang Tu, Chia-Ming Chang,
More informationThe use of prescription psychotropic medication in
DRUGS AND PHARMACOLOGY Effect of Age on the Profile of Psychotropic Users: Results from the 2010 National Ambulatory Medical Care Survey Donovan T. Maust, MD,* David W. Oslin, MD, and Steven C. Marcus,
More informationBenzodiazepines. Benzodiazepines
: History 1950s - Invented by Swiss chemists who identified its sedative effects 1950s 60s - Chlordiazepoxide (Librium) marketed as a safer alternative to barbiturates; along with newer benzodiazepines
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationOutline. Disclosure. Sleep and the Elderly 1,2. Background
Geriatric Grand Rounds Tuesday, March 31, 29 12: noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this
More informationANTIDEPRESSANT MEDICATION & RISK OF DEMENTIA
ANTIDEPRESSANT MEDICATION & RISK OF DEMENTIA A Nationwide Cohort Study in Taiwan / Speaker: Chee-Kin Then / Advisor: Prof. Shing-Chuan Shen / Unit: Graduate Institute of Medical Sciences / Date: 2017.04.
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
More informationSupplemental Digital Content
CNS Drugs The Relationship between Benzodiazepine Use and Traffic Accidents A Systematic Literature Review Beitske E. Smink, et al. Supplemental Digital Content This Supplemental Digital Content contains
More informationCANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE
CANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE Aliya Kassam 1, Scott B Patten 2 1 Institute of Psychiatry, London, UK, 2 Department of Community Health Sciences, University of Calgary, Calgary, Alberta,
More informationMEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine
MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA Federica Edith Pisa University Hospital Udine BACKGROUND Polypharmacy and psychotropic medication use are
More information- how many anti-depressant pills were prescribed to patients in years 2011/12/13
NHS Wet Kent Clinical Commiioning Group Our Ref: FOI.14.WK0196 RE: FREEDOM OF INFORMATION REQUEST Thank you for your requet for information under the Freedom of Information Act 2000 received on 25 February
More informationDo benzos, opioids, or strong anticholinergics cause delirium? Lisa Burry
Do benzos, opioids, or strong anticholinergics cause delirium? Lisa Burry Delirium in the ICU Occurs in up to 85% of MICU/SICU MV patients 20-50% of lower severity ICU patients develop delirium Hypoactive
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationTITLE: Benzodiazepines in Older Adults: A Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines
TITLE: Benzodiazepines in Older Adults: A Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines DATE: 22 November 2010 EXECUTIVE SUMMARY Context and Policy Issues BZDs have been associated
More informationA Retrospective Claims Analysis of Medication Adherence and. Persistence Among Patients Taking Antidepressants
A Retrospective Claims Analysis of Medication Adherence and Persistence Among Patients Taking Antidepressants for the Treatment of Major Depressive Disorder (MDD) Katelyn R. Keyloun A thesis submitted
More informationDeprescribing Benzodiazepines in Hospitalized Seniors Using a Patient-Education Intervention
Deprescribing Benzodiazepines in Hospitalized Seniors Using a Patient-Education Intervention PRESENTERS Jean Triscott, MD, CCFP (COE) Frances Carr, MBChB, FRCPC Correspondence to: Fcarr@ualberta.ca Frances
More informationUpdate on Falls Prevention Research
Update on Falls Prevention Research Jasmine Menant NSW Falls Prevention Network Rural Forum 24 th August 2018 Acknowledgements: Prof Stephen Lord, Dr Daina Sturnieks Recent falls risk factor studies Lubaszy
More informationClinical impact of potentially inappropriate medications during hospitalization of acutely ill older patients with multimorbidity
Scandinavian Journal of Primary Health Care ISSN: 0281-3432 (Print) 1502-7724 (Online) Journal homepage: http://www.tandfonline.com/loi/ipri20 Clinical impact of potentially inappropriate medications during
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationThe Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State
The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State RAI/MDS Coordinator Objectives Upon completion of this training,
More informationReduction in the Use of Night Sedation to Reduce the Risk of Falls
Reduction in the Use of Night Sedation to Reduce the Risk of Falls Ms Margaret Hargraves Hospital Pharmacist Prince of Wales Hospital South Eastern Sydney Illawarra Area Health Service Objectives Falls
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationTreating sleep disorders
Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with
More informationAppropriateness of prescribing in older patients
Appropriateness of prescribing in older patients Which tools should be used? Anne Spinewine MPharm, MSc, PhD Université catholique de Louvain, Belgium Louvain Drug Research Institute and CHU Mont-Godinne
More informationZ-drugs and risk of falls and fractures: A systematic review and metaanalysis
Originally submitted to academic advisory board: February 2015 Revised: September 2017 Z-drugs and risk of falls and fractures: A systematic review and metaanalysis - Protocol Nir Treves, Amichai Perlman,
More informationAntidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database
open access Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database Carol Coupland, 1 Trevor Hill, 1 Richard Morriss,
More informationBriefing Document on Medication use and Falls
Briefing Document on Medication use and Falls This document is intended as a briefing document and is not to be regarded as a document offering definitive legal advice in relation to the subject matter.
More informationSERVICE USER INFORMATION
SERVICE USER INFORMATION 1 Age on admission 2 Gender Male Female 3 Ethnicity White British White Irish Any other white background White and Black Caribbean White and Black African White and Asian Any other
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationCompleted audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia
Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia Victor M. Aziz, Natalie Hill, Sugandha Kumar BJPsych Bulletin (08) 4,
More informationPolypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit
INTERNATIONAL JOURNAL of BIOMEDICAL SCIENCE ORIGINAL ARTICLE Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit Joanna Ulley 1, Sakila Sickander 2, Ahmed H.
More informationSupplementary Online Content
Supplementary Online Content Viktorin A, Uher R, Kolevzon A, Reichenberg A, Levine SZ, Sandin S. Association of antidepressant medication use during pregnancy with intellectual disability in offspring.
More informationDepression and use of antidepressants in Swedish nursing homes: a 12-month followup study.
Depression and use of antidepressants in Swedish nursing homes: a 12-month followup study. Midlöv, Patrik; Andersson, Martin L; Östgren, Carl Johan; Mölstad, Sigvard Published in: International Psychogeriatrics
More informationPolicy Evaluation: Low Dose Quetiapine Safety Edit
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University 500 Summer Street NE, E35, Salem, Oregon 97301 1079 Phone 503 947 5220 Fax 503
More informationThe confused older patient: A practice audit, nurse beliefs and the epidemiology of falls and fall injuries
School of Public Health and Preventive Medicine The confused older patient: A practice audit, nurse beliefs and the epidemiology of falls and fall injuries Ms Renata Morello 6-PACK Project Manger B.Phty,
More informationBMJ Open. Pharmacology and therapeutics. Maternal medicine < OBSTETRICS, Depression & mood disorders < PSYCHIATRY, EPIDEMIOLOGY
Combined use of selective serotonin reuptake inhibitor and sedatives/hypnotics during pregnancy: Risk of relatively severe congenital malformations or cardiac defects. A register study Journal: Manuscript
More informationGUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS
City and County of San Francisco Mayor Gavin Newsom Department of Public Health Community Behavioral Health Services 1380 Howard Street 5 th Floor San Francisco, CA 94103 GUIDELINES FOR THE USE OF PSYCHOACTIVE
More informationPolypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP
Polypharmacy in the Elderly Lesley Charles, MBChB, CCFP Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta March 06, 2016 1 Faculty/Presenter
More informationUse of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia
Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,
More informationInappropriate benzodiazepine use in older adults and the risk of fracture
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2008.03185.x Inappropriate benzodiazepine use in older adults and the risk of fracture Cornelis S. van der Hooft, 1,2,3 Mariëtte W. C. J.
More informationGeri-PARDY! (2015 Beers Criteria) Pharmacology Edition
Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria
More informationSurgery in Frail Elders. Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011
Surgery in Frail Elders Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011 What we re going to cover Mortality after surgery in the elderly Fact v Fantasy
More informationInterventions to improve medication use in elderly primary care patients
Interventions to improve medication use in elderly primary care patients Lenander, Cecilia Published: 2017-01-01 Document Version Publisher's PDF, also known as Version of record Link to publication Citation
More informationAsian Journal of Phytomedicine and Clinical Research Journal home page:
Research Article CODEN: AJPCFF ISSN: 2321 0915 Asian Journal of Phytomedicine and Clinical Research Journal home page: www.ajpcrjournal.com STUDY OF ADR OF BENZODIAZEPINE S AT A PRIVATE CORPORATE HOSPITAL
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationMR04A3 An isoindoline derivative, New Sedative/Anesthetic Agent
MR04A3 An isoindoline derivative, ew Sedative/Anesthetic Agent ovember 2009 1 Introduction Sedatives are widely used in: Settings providing stressful and painful procedures Gastroenterology (colonoscopy
More informationManual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
More informationSpecial Project. National Mental Health Benchmarking Project Forensic Forum. Seclusion Medication Audit
National Mental Health Benchmarking Project Forensic Forum Special Project Seclusion Medication Audit A joint Australian, State and Territory Government Initiative October 2007 National Benchmarking Project
More informationAnxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif
Anxiolytic & Hypnotic Drugs Asst Prof Dr Inam S Arif isamalhaj@yahoo.com Anxiolytic & Hpnotic Agents Anxiety: unpleasant state of tension, apprehension or uneasiness, characterised by, tachycardia, sweating,
More informationAntidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database
open access Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database Carol Coupland, 1 Trevor Hill, 1 Richard Morriss, 2 Michael Moore, 3
More informationOHSU Drug Effectiveness Review Project Summary Report Benzodiazepines
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationPerinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2015) Principal Author: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
More informationA guide to reducing or stopping mental health medication. Notes for prescribers
A guide to reducing or stopping mental health medication Notes for prescribers 1 Prescribers notes for reducing or stopping mental health medication These notes are written to augment the information for
More informationPediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form
Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form Please fax form to 617.673.0988 or mail to Tufts Health Plan, 705 Mount Auburn Street, Watertown, MA 02472, Attn:
More informationThere s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor
More informationDavid Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy
David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy It s no dream. Sleep well without sleeping pills. Outline Baby boomers & beyond: medication use Deprescribing
More informationSummary of Delirium Clinical Practice Guideline Recommendations Post Operative
Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationExecutive Summary. Classes Under Review: Analysis:
Outcome Report on MHQAC Edits Classes Under Review: Analysis: Atypical Antipsychotics, SSRIs, SNRIs, Antianxietals, Hypnotics, and Drugs to Treat ADD/ADHD Utilization and Cost Trends: Pre and Post Implementation
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationPredicting which medication classes interfere with allergy skin testing
Predicting which medication classes interfere with allergy skin testing Kunal M. Shah, M.D, 1 Matthew A. Rank, M.D., 1 Shoban A. Davé, M.D., 2 Corrine L. Oslie, R.N., 1 and Joseph H. Butterfield, M.D.
More information